AngioDynamics Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AngioDynamics, Inc. on July 25, 2016, covering events occurring on July 19, 2016. The filing primarily addresses Item 5.02 regarding the appointment of a new Chief Financial Officer and the departure of a Senior Vice President.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive compensation and personnel changes.
Material Changes and Personnel Actions
- Appointment of CFO: Michael Greiner was appointed Executive Vice President and Chief Financial Officer, effective August 16, 2016. He previously served as CFO of Extreme Reach, Inc.
- Departure of Executive: Mark Stephens, Senior Vice President of Administration, agreed to leave the company effective on a date to be determined.
Compensation and Employment Terms
Michael Greiner (New CFO):
- Base Salary: $370,000 per year.
- Annual Bonus: Target level of 60% of base salary, beginning with the fiscal year ending May 31, 2017.
- Sign-on Bonus: $100,000 approved by the Compensation Committee.
- Equity Awards (Effective Aug 16, 2016):
- 20,000 performance shares (3-year term, payout 0-200% based on TSR).
- Option to purchase 100,000 shares (vests over 4 years, expires Aug 16, 2023).
- 10,000 restricted stock units (vests over 4 years).
- Allowances: $1,200 monthly car allowance and $75,000 relocation allowance.
- Employment Status: "At-will" basis.
Mark Stephens (Departing SVP):
- Severance: Continuation of annual base salary for 12 months plus earned but unused vacation time, contingent upon a waiver and general release of claims.
Outlook and Risks
The filing does not contain forward-looking guidance, management commentary on business outlook, or specific risk factors beyond the standard "at-will" employment terms.
Key Facts for Investor Verification
- Verify the effective start date of Michael Greiner's tenure (August 16, 2016) and the transition timeline for the CFO role.
- Confirm the specific departure date for Mark Stephens, which was not finalized at the time of filing.
- Review the performance metrics for the 20,000 performance shares granted to Mr. Greiner to understand the payout conditions relative to peer group Total Shareholder Return (TSR).
- Assess the impact of the $100,000 sign-on bonus and $75,000 relocation allowance on the company's immediate cash flow and compensation expense.